title: [Systematic preventive antibiotic therapy during hysterosalpingography in an African tropical environment: is this practice justified?].
abstract: To find out whether preventive antibiotic therapy can be justified in the practice of hysterosalpingography in a tropical environment where the infectious risk is notoriatly high, the authors performed a prospective study concerning 49 females patients. The patients in genital activity period, were willing and volunteers and were aged from 20 to 44 years. They were examined by hysterosalpingography during a period of three months. Patients were distributed in two homogenous group, one group of 25 patients who had a preventive antibiotic therapy and the second group with 24 patients with no preventive antibiotic therapy. Hysterosalpingography examinations were performed with sterile and single-use equipment. All patients were clinically examined for medical record purposes: gynaecologic, obstetric, pelvic infection, oral contraception, previous hysterosalpingography. Biologic dosages were realized, including blood count and erythrocyte sedimentation, culture of vaginal sampling, C reactive protein rate. The results obtained showed no significant difference between the two groups. The authors conclude that hysterosalpingography can be also performed in a tropical environment without using systematic preventive antibiotic therapy provided that asepsisrules are strictly observed.
authors.affiliation: Service de radiologie, CHU de Yopougon, 21 BP 632, Abidjan 21, Cote d'Ivoire.
authors.forename: Roger Daniel
authors.initials: RD
authors.lastname: N'Gbesso
authors.forename: Bangali
authors.initials: B
authors.lastname: Tan
authors.forename: Mohamed Ould
authors.initials: MO
authors.lastname: Beddi
authors.forename: Guillaume
authors.initials: G
authors.lastname: Quenum
mesh_terms: D000328:Adult; D000658:Amoxicillin / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis / Q000592:standards*; D001207:Asepsis / Q000379:methods; D007560:Cote d'Ivoire / Q000453:epidemiology; D003428:Cross Infection / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D003967:Diarrhea / Q000209:etiology; D005260:Female; D005334:Fever / Q000209:etiology; D006801:Humans; D007047:Hysterosalpingography / Q000009:adverse effects*; D017053:Infection Control / Q000379:methods*; D018579:Patient Selection; D017699:Pelvic Pain / Q000209:etiology; D010406:Penicillins / Q000627:therapeutic use; D011322:Primary Prevention / Q000379:methods; D011446:Prospective Studies; D012307:Risk Factors; D016896:Treatment Outcome; D014330:Tropical Medicine; D014592:Uterine Hemorrhage / Q000209:etiology
chemical_list: D010406:Penicillins; D000658:Amoxicillin